P&G appoints Gopalakrishnan Kalianna as Sales Head effective Aug 1, 2026

Procter & Gamble Hygiene and Health Care Limited has appointed Mr. Gopalakrishnan Kalianna as the Sales Head of the company, effective August 1, 2026. The appointment was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. Mr. Gopalakrishnan takes over from Ms. Rohini Venkateswaran, who will cease to be the Sales Head effective close of business hours on July 31, 2026, as she assumes a new role as Senior Vice President–Korea within the P&G organization.

Mr. Gopalakrishnan is a seasoned business leader with over two decades of experience across brands, channels, and markets, including extensive work in India and West Africa. He currently leads P&G India's Go-To-Market strategy and Fabric Care Sales. Known for strategic clarity and disciplined execution, he has delivered sustainable top-line growth, margin expansion, and led high-performing teams. His professional background includes leading P&G India's Southwest Division and serving as the Category Leader for the Oral Care category. He completed his MBA in Marketing from SP Jain Institute of Management and Research in 2006.

Management Transition Details

The transition involves the following key changes effective August 1, 2026:

Role	Incumbent	Status	New Role/Location
Sales Head	Gopalakrishnan Kalianna	Appointed	Sales Head, P&G Hygiene and Health Care Limited
Sales Head	Rohini Venkateswaran	Ceased	Senior Vice President–Korea

Ms. Venkateswaran expressed gratitude to the company leadership team for their support during her tenure as a leadership team member. The company disclosed these changes in a filing submitted to the stock exchanges on July 1, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.31%	-1.67%	-1.58%	-28.26%	-32.81%	-31.74%

Procter & Gamble Overseas India B.V., the promoter of Procter and Gamble Health Limited, has confirmed that it holds 51.82% of the target company's total paid-up share capital without any encumbrance as of March 31, 2026. The disclosure was submitted to the stock exchanges pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The promoter group, along with Persons Acting in Concert (PACs), holds a total of 86,01,071 shares. The filing explicitly states that no shares have been encumbered, directly or indirectly, during the financial year ended March 31, 2026.

Shareholding Details

The following table outlines the shareholding structure disclosed by the promoter:

Name of listed company (target company)	Procter and Gamble Health Limited
Name of stock exchanges where shares are listed	BSE Limited National Stock Exchange of India Limited
Name of the promoter(s) / PACs	Procter and Gamble Overseas India B.V.
Promoter shareholding	86,01,071 shares (51.82% of paid-up share capital)
Encumbered shares as a % of promoter shareholding	NIL

The declaration was signed by K. Leizer, Authorized Signatory for Procter & Gamble Overseas India B.V., on April 2, 2026. A copy of the disclosure was also marked to the Audit Committee of Procter and Gamble Health Limited.